Evaluation of the Safety and Efficacy of a Vascular Prosthesis as an Above-Knee Bypass Graft in Patients With PAD
A Pilot Study for Evaluation of the Safety and Efficacy of Humacyte's Human Acellular Vascular Graft as an Above-Knee Femoro-Popliteal Bypass Graft in Patients With Peripheral Arterial Disease
Sponsor: FGK Clinical Research GmbH
A NA clinical study on Peripheral Arterial Disease and Peripheral Vascular Disease, this trial is completed. The trial is conducted by FGK Clinical Research GmbH and has accumulated 15 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
15 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Dec 2024 — Sep 2025 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting NA
▶ Show 10 earlier versions
-
Sep 2022 — Oct 2023 [monthly]
Active Not Recruiting NA
-
Jan 2022 — Sep 2022 [monthly]
Active Not Recruiting NA
-
Apr 2021 — Jan 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Nov 2019 — Mar 2020 [monthly]
Active Not Recruiting NA
-
Feb 2019 — Nov 2019 [monthly]
Active Not Recruiting NA
-
Sep 2018 — Feb 2019 [monthly]
Active Not Recruiting NA
-
Jun 2018 — Sep 2018 [monthly]
Active Not Recruiting NA
-
Jan 2017 — Jun 2018 [monthly]
Active Not Recruiting NA
First recorded
Oct 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- FGK Clinical Research GmbH
- Humacyte, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .